Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: NEOPLASMS, EXPERIMENTAL - GENETICS , . Treffer: 10
2017
Nelson, ME; Lahiri, S; Chow, JD; Byrne, FL; Hargett, SR; Breen, DS; Olzomer, EM; Wu, LE; Cooney, GJ; Turner, N; James, DE; Slack-Davis, JK; Lackner, C; Caldwell, SH; Hoehn, KL
Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
Nat Commun. 2017; 8(6):14689-14689
Doi: 10.1038/ncomms14689
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Kessler, SM; Laggai, S; Barghash, A; Schultheiss, CS; Lederer, E; Artl, M; Helms, V; Haybaeck, J; Kiemer, AK
IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.
Cell Death Dis. 2015; 6(1):e1894-e1894
Doi: 10.1038/cddis.2015.241
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wenzl, K; Troppan, K; Neumeister, P; Deutsch, AJ
The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
Curr Drug Targets. 2015; 16(1):38-46
Doi: 10.2174/1389450115666141120112818
Web of Science
PubMed
FullText
FullText_MUG
Zuckermann, M; Hovestadt, V; Knobbe-Thomsen, CB; Zapatka, M; Northcott, PA; Schramm, K; Belic, J; Jones, DT; Tschida, B; Moriarity, B; Largaespada, D; Roussel, MF; Korshunov, A; Reifenberger, G; Pfister, SM; Lichter, P; Kawauchi, D; Gronych, J
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling.
Nat Commun. 2015; 6(3):7391-7391
Doi: 10.1038/ncomms8391
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Katz, SF; Lechel, A; Obenauf, AC; Begus-Nahrmann, Y; Kraus, JM; Hoffmann, EM; Duda, J; Eshraghi, P; Hartmann, D; Liss, B; Schirmacher, P; Kestler, HA; Speicher, MR; Rudolph, KL
Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation.
Gastroenterology. 2012; 142(5):1229-1239
Doi: 10.1053/j.gastro.2012.02.009
Web of Science
PubMed
FullText
FullText_MUG
Musteanu, M; Blaas, L; Zenz, R; Svinka, J; Hoffmann, T; Grabner, B; Schramek, D; Kantner, HP; Müller, M; Kolbe, T; Rülicke, T; Moriggl, R; Kenner, L; Stoiber, D; Penninger, JM; Popper, H; Casanova, E; Eferl, R
A mouse model to identify cooperating signaling pathways in cancer.
Nat Methods. 2012; 9(9):897-900
Doi: 10.1038/nmeth.2130
Web of Science
PubMed
FullText
FullText_MUG
2008
Hüsemann, Y; Geigl, JB; Schubert, F; Musiani, P; Meyer, M; Burghart, E; Forni, G; Eils, R; Fehm, T; Riethmüller, G; Klein, CA
Systemic spread is an early step in breast cancer.
Cancer Cell. 2008; 13(1):58-68
Doi: 10.1016/j.ccr.2007.12.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pressetext
2003
Pineda Torra, I; Claudel, T; Duval, C; Kosykh, V; Fruchart, JC; Staels, B
Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Mol Endocrinol. 2003; 17(2):259-272
Doi: 10.1210/me.2002-0120
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2001
Nestl, A; Von Stein, OD; Zatloukal, K; Thies, WG; Herrlich, P; Hofmann, M; Sleeman, JP
Gene expression patterns associated with the metastatic phenotype in rodent and human tumors.
Cancer Res. 2001; 61(4):1569-1577
[OPEN ACCESS]
Web of Science
PubMed
FullText
Google Scholar
1986
Gamperl, R
Chromosome abnormalities in bovine papillomavirus type 1-transformed Syrian hamster cells before and after tumor formation.
Cancer Genet Cytogenet. 1986; 20(3-4):355-362
Doi: 10.1016/0165-4608(86)90095-6
Web of Science
PubMed
FullText
FullText_MUG